Baxalta Belgium Manufacturing S.A.
PolandAll drugs from this manufacturer
-
The medicine is intended for patients with a weakened immune system who have an antibody deficiency and a tendency toward frequent infections. It is used for replacement therapy in individuals with congenital antibody deficiency and in patients with secondary immunodeficiency resulting from other diseases or treatments.
Dosage form: solution for injection
Active substance Dosage human normal immunoglobulin 1 g, 2 g, 4 g or 8 g ATC: J06BA01